No Appeal of LDT/FDA Lawsuit

No Appeal of LDT/FDA Lawsuit

The FDA had until May 30 to appeal U.S. District Court Judge Sean D. Jordan's decision to vacate the agency's Final Rule seeking to regulate laboratory developed tests (LDTs). The federal government declined to appeal the judge's decision meaning the Texas District Court's decision to vacate, in its entirety, the FDA's attempt to regulate LDTs as medical devices stands.

Read ACLA’s full lawsuit.

Read the Final Judgment.

 

CMS Seeking Comment on CLIA Rule Allowing Remote Access to Digital Laboratory Data

CMS Seeking Comment on CLIA Rule Allowing Remote Access to Digital Laboratory Data

The Centers for Medicare & Medicaid Services is seeking comment on a proposed rule to amend regulations from the Clinical Laboratory Improvement...

Read More
Bill to Reform No Surprises Act Arbitration Process Introduced in House

Bill to Reform No Surprises Act Arbitration Process Introduced in House

Rep. Frank Pallone (D-N.J.), ranking member of the House Energy & Commerce Committee, introduced legislation to fix the No Surprises Act arbitration...

Read More
UHC Drops Lp(a) from Its Non-Coverage List

UHC Drops Lp(a) from Its Non-Coverage List

UnitedHealthcare has released an updated version of its Cardiovascular Disease Risk Tests medical policy for Commercial and Individual Exchange...

Read More